4'Cl-CUMYL-PINACA

4'Cl-CUMYL-PINACA
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Class B;
Identifiers
	IUPAC name N-[2-(4-chlorophenyl)propan-2-yl]-1-pentylindazole-3-carboxamide;
CAS Number	1631074-65-1;
PubChem CID	86274160;
ChemSpider	71117114;
CompTox Dashboard (EPA)	DTXSID001345334 ;
Chemical and physical data
Formula	C22H26ClN3O
Molar mass	383.92 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCCCN1C2=CC=CC=C2C(=N1)C(=O)NC(C)(C)C3=CC=C(C=C3)Cl;
	InChI InChI=1S/C22H26ClN3O/c1-4-5-8-15-26-19-10-7-6-9-18(19)20(25-26)21(27)24-22(2,3)16-11-13-17(23)14-12-16/h6-7,9-14H,4-5,8,15H2,1-3H3,(H,24,27); Key:APEGZJKYOJZGKH-UHFFFAOYSA-N;

4'Cl-CUMYL-PINACA (also known as SGT-157) is an indazole-3-carboxamide based synthetic cannabinoid compound, first disclosed in a 2014 patent.^[1] It has been sold as a designer drug, first reported in 2020 alongside two similar compounds 4'F-CUMYL-5F-PICA (SGT-64) and 4'F-CUMYL-5F-PINACA (SGT-65),^[2] and the metabolism of these compounds has been studied to assist with their identification in forensic casework.^[3]

References

^ WO 2014167530, Bowden MJ, Williamson JP, "Cannabinoid compounds", published 16 October 2014.
^ Zangani C, Schifano F, Napoletano F, Arillotta D, Gilgar L, Guirguis A, et al. (2020). "The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online". Current Neuropharmacology. 18 (10): 966–1051. doi:10.2174/1570159X18666200302125146. PMC 7709145. PMID 32116194.
^ Stalberga D, Ingvarsson S, Bessa G, Maas L, Vikingsson S, Persson M, et al. (December 2022). "Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis" (PDF). Basic & Clinical Pharmacology & Toxicology. 132 (3): 263–280. doi:10.1111/bcpt.13829. PMID 36544361. S2CID 255039508.

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

[1] WO 2014167530, Bowden MJ, Williamson JP, "Cannabinoid compounds", published 16 October 2014.

[pmid32116194-2] Zangani C, Schifano F, Napoletano F, Arillotta D, Gilgar L, Guirguis A, et al. (2020). "The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online". Current Neuropharmacology. 18 (10): 966–1051. doi:10.2174/1570159X18666200302125146. PMC 7709145. PMID 32116194.

[pmid36544361-3] Stalberga D, Ingvarsson S, Bessa G, Maas L, Vikingsson S, Persson M, et al. (December 2022). "Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis" (PDF). Basic & Clinical Pharmacology & Toxicology. 132 (3): 263–280. doi:10.1111/bcpt.13829. PMID 36544361. S2CID 255039508.

[1]

[2]

[3]

Legal status

Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Class B
Identifiers
IUPAC name N-[2-(4-chlorophenyl)propan-2-yl]-1-pentylindazole-3-carboxamide
CAS Number	1631074-65-1
PubChem CID	86274160
ChemSpider	71117114
CompTox Dashboard (EPA)	DTXSID001345334
Chemical and physical data
Formula	C₂₂H₂₆ClN₃O
Molar mass	383.92 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES CCCCCN1C2=CC=CC=C2C(=N1)C(=O)NC(C)(C)C3=CC=C(C=C3)Cl
InChI InChI=1S/C22H26ClN3O/c1-4-5-8-15-26-19-10-7-6-9-18(19)20(25-26)21(27)24-22(2,3)16-11-13-17(23)14-12-16/h6-7,9-14H,4-5,8,15H2,1-3H3,(H,24,27) Key:APEGZJKYOJZGKH-UHFFFAOYSA-N

4'Cl-CUMYL-PINACA

See also

References